Shilpa Medicare Ltd vs Sun Pharmaceutical Industries Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Shilpa Medicare Ltd currently has the stronger revenue growth signal.
Neither company currently shows a clear active capex signal.
No strong fundraising signal is currently visible for either company.
| Metric | Shilpa Medicare Ltd | Sun Pharmaceutical Industries Ltd |
|---|---|---|
| Current Price | ₹1,021 | ₹1,837 |
| Market Cap | ₹18,798.35 Cr. | ₹4.41 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 66.11 | 34.95 |
| ROE (%) | 8.99 | 15.95 |
| Debt/Equity | 0.25 | 0.06 |
| Sales Growth 5Y (%) | 11.3 | 11.78 |
| Profit Growth 5Y (%) | 202.34 | 2.54 |
| Promoter Holding (%) | 40.13 | 54.48 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | No | No information |
| Fundraise | No | No information |